Topic: pharmacy benefit management
One of the nation's largest PBMs is shaking up its payment model by building in "net cost predictability."
The Trump administration has yet to unveil its plan for overhauling safe harbors for drug rebates, but experts say there's limits on what it can do.
CMS officials announced on Monday that the agency is considering a policy that would require pharmacy rebates to be passed on to seniors.
CVS Health said it expects to finalize its $69 billion acquisition of Aetna in the next two weeks, with five states left to approve the deal.
Despite railing against the role of middlemen—namely PBMs—in rising drug prices, HHS appears poised to introduce some into Part B.
After acquiring a 28% stake in RxAdvance, Centene plans to kick off a national rollout in 2018.
CMS wants drug companies to put their list prices in television ads, but whether that policy is something it can enforce remains a major question.
UnitedHealth disclosed the purchase of Avella Specialty Pharmacy and reported $3.2 billion in net earnings.
Consumer organizations are disappointed in the deal, but industry experts say what happens next remains up in the air.
President Donald Trump signed two bipartisan bills into law on Wednesday that would ban so-called gag clauses at the pharmacy counter.